The Perioperative and Operative Management of Esophageal and Gastric Cancer

Amn Siddiqi; Fabian M Johnston

doi:10.1016/j.soc.2022.07.006

The Perioperative and Operative Management of Esophageal and Gastric Cancer

Surg Oncol Clin N Am. 2023 Jan;32(1):65-81. doi: 10.1016/j.soc.2022.07.006. Epub 2022 Nov 3.

Authors

Amn Siddiqi¹, Fabian M Johnston²

Affiliations

¹ Department of Surgery, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287, USA.
² Division of Gastrointestinal Surgical Oncology, Johns Hopkins University, 600 North Wolfe Street, Baltimore, MD 21287, USA. Electronic address: [email protected].

PMID: 36410922
DOI: 10.1016/j.soc.2022.07.006

Abstract

Optimal management of esophageal and gastric cancer during the perioperative period requires a coordinated multidisciplinary treatment effort. Accurate staging guides treatment strategy. Advances in minimally invasive surgery and endoscopy have reduced risks associated with resection while maintaining oncological standards. Although the standard perioperative chemo-and radiotherapy regimens have not yet been established, randomized control trials exploring this subject show promising results.

Keywords: CROSS; CRS + HIPEC; D1 versus D2 lymphadenectomy; Esophageal cancer; Esophagogastric cancer; FLOT; Gastric cancer; RAMIE.

Publication types

Review

MeSH terms

Esophageal Neoplasms* / surgery
Esophagectomy / methods
Humans
Minimally Invasive Surgical Procedures / methods
Stomach Neoplasms* / surgery